Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Development of Megakaryocyte-Specific Lentiviral Vectors for Gene Therapy of Platelet Disorders.

Liesbeth De Waele, MD, Kathleen Freson, PhD, Chantal Thys, Christel Van Geet, MD, PhD, Désiré Collen, MD, PhD, Thierry VandenDriessche, PhD, Marinee Chuah, PhD

Blood (2007) 110 (11): 5143.

https://doi.org/10.1182/blood.V110.11.5143.5143

Published: 2007

Journal Articles

Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor

Simon F. De Meyer, Karen Vanhoorelbeke, Marinee K. Chuah, Inge Pareyn, Veerle Gillijns, Robert P. Hebbel, Désiré Collen, Hans Deckmyn, Thierry VandenDriessche

Blood (2006) 107 (12): 4728–4736.

https://doi.org/10.1182/blood-2005-09-3605

Published: 2006

Journal Articles

Growth Arrest-Specific Gene 6 (Gas6) Deficiency in Mice Alleviates Graft-versus-Host Disease (GVHD) in the Liver.

Laurent Burnier, Jean-Marc Herbert, Pierre Savi, Désiré Collen, Edward M. Conway, Peter Carmeliet, Shozo Izui, Anne Angelillo-Scherrer

Blood (2004) 104 (11): 3071.

https://doi.org/10.1182/blood.V104.11.3071.3071

Published: 2004

Journal Articles

Critical Amplification by Gas6 of the Epo-Dependent Erythropoietic Response to Anemia: Novel Opportunities for Anemia Treatment.

Anne Angelillo-Scherrer, Laurent Burnier, Richard Fish, Stéphane Plaisance, Eduardo Martinez-Soria, Patrick Maxwell, Désiré Collen, Shozo Izui, Edward M. Conway, Peter Carmeliet

Blood (2004) 104 (11): 459.

https://doi.org/10.1182/blood.V104.11.459.459

Published: 2004

Journal Articles

Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells

Bart R. De Geest, Sophie A. Van Linthout, Désiré Collen

Blood (2003) 101 (7): 2551–2556.

https://doi.org/10.1182/blood-2002-07-2146

Published: 2003

Journal Articles

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

Marinee K. L. Chuah, Gudrun Schiedner, Lieven Thorrez, Brian Brown, Marion Johnston, Veerle Gillijns, Sabine Hertel, Nico Van Rooijen, David Lillicrap, Désiré Collen, Thierry VandenDriessche, Stefan Kochanek

Blood (2003) 101 (5): 1734–1743.

https://doi.org/10.1182/blood-2002-03-0823

Published: 2003

Journal Articles

Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia

Gregor Theilmeier, Carine Michiels, Erik Spaepen, Ingrid Vreys, Désiré Collen, Jos Vermylen, Marc F. Hoylaerts

Blood (2002) 99 (12): 4486–4493.

https://doi.org/10.1182/blood.V99.12.4486

Published: 2002

Journal Articles

Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model

Inderjit Singh, Alberto Smith, Beatrijs Vanzieleghem, Désiré Collen, Kevin Burnand, Jean-Marie Saint-Remy, Marc Jacquemin

Blood (2002) 99 (9): 3235–3240.

https://doi.org/10.1182/blood.V99.9.3235

Published: 2002

Journal Articles

Depletion of circulating α 2 -antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization

Nobus Nagai, Maria De Mol, Berthe Van Hoef, Maria Verstreken, Désiré Collen

Blood (2001) 97 (10): 3086–3092.

https://doi.org/10.1182/blood.V97.10.3086

Published: 2001

Journal Articles

Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes

Yves Laroche, Stephane Heymans, Sophie Capaert, Frans De Cock, Eddy Demarsin, Désiré Collen

Blood (2000) 96 (4): 1425–1432.

https://doi.org/10.1182/blood.V96.4.1425

Published: 2000

Journal Articles

Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions

Edward M. Conway, Saskia Pollefeyt, Jan Cornelissen, Inky DeBaere, Marta Steiner-Mosonyi, Kelly Ong, Mathijs Baens, Désiré Collen, Andre C. Schuh

Blood (2000) 95 (4): 1435–1442.

https://doi.org/10.1182/blood.V95.4.1435.004k01_1435_1442

Published: 2000

Journal Articles

Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase

Sophie Vanwetswinkel, Stephane Plaisance, Zhang Zhi-yong, Ingrid Vanlinthout, Kathleen Brepoels, Ignace Lasters, Désiré Collen, Laurent Jespers

Blood (2000) 95 (3): 936–942.

https://doi.org/10.1182/blood.V95.3.936.003k20_936_942

Published: 2000

Journal Articles

Circulating Activated Platelets Assist THP-1 Monocytoid/Endothelial Cell Interaction Under Shear Stress

Gregor Theilmeier, Tim Lenaerts, Claude Remacle, Désiré Collen, Jos Vermylen, Marc F. Hoylaerts

Blood (1999) 94 (8): 2725–2734.

https://doi.org/10.1182/blood.V94.8.2725.420k18_2725_2734

Published: 1999

Journal Articles

Structure-Function Analyses of Thrombomodulin by Gene-Targeting in Mice: The Cytoplasmic Domain Is Not Required for Normal Fetal Development

Edward M. Conway, Saskia Pollefeyt, Jan Cornelissen, Inky DeBaere, Marta Steiner-Mosonyi, Jeffrey I. Weitz, Hartmut Weiler-Guettler, Peter Carmeliet, Désiré Collen

Blood (1999) 93 (10): 3442–3450.

https://doi.org/10.1182/blood.V93.10.3442.410k17_3442_3450

Published: 1999

Journal Articles

Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing Mice

Peter Carmeliet, Jean-Marie Stassen, Ilse Van Vlaenderen, Robert S. Meidell, Désiré Collen, Robert D. Gerard

Blood (1997) 90 (4): 1527–1534.

https://doi.org/10.1182/blood.V90.4.1527

Published: 1997

NARROW

Development of Megakaryocyte-Specific Lentiviral Vectors for Gene Therapy of Platelet Disorders.

Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor

Growth Arrest-Specific Gene 6 (Gas6) Deficiency in Mice Alleviates Graft-versus-Host Disease (GVHD) in the Liver.

Critical Amplification by Gas6 of the Epo-Dependent Erythropoietic Response to Anemia: Novel Opportunities for Anemia Treatment.

Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia

Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model

Depletion of circulating α 2 -antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization

Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes

Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions

Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase

Circulating Activated Platelets Assist THP-1 Monocytoid/Endothelial Cell Interaction Under Shear Stress

Structure-Function Analyses of Thrombomodulin by Gene-Targeting in Mice: The Cytoplasmic Domain Is Not Required for Normal Fetal Development

Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator–Deficient and Plasminogen Activator Inhibitor-1–Overexpressing Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only